Back to results
US 2026/0124276 A1Published application
Bioengineering teritiary lymphoid structures using chitosan-based hydrogels
AssigneeH. Lee Moffitt Cancer Center and Research Institute, Inc.
InventorsJames Mulé, Rana Falahat, Genyuan Zhu
Life of this patent
Estimating the term…
Abstract
As disclosed herein, stromal cells are important for the recruitment and organization of lymphocytes in TLSs. Therefore, disclosed herein are composition and methods for bioengineering TLSs in animals, such as mice. These compositions involve chemokine-releasing microparticles or cells that can be implanted into the animals. Therefore, disclosed herein are chitosan hydrogels with chemokine-releasing microparticles or cells.
Claims13
A composition comprising chemokine-releasing microparticles or cells embedded in a chitosan hydrogel.
Dependencies are inferred from the claim text.